Mirati Therapeutics Aktie

Kaufen
Verkaufen
Aktien, ETFs, Sparpläne & Kryptos zu Top-Konditionen beim Testsieger von finanztip.de handeln! Bei einem anderen Broker handeln Smartphone
Div. Rendite 0,00%

WKN A1W1XV

ISIN US60468T1051

Symbol MRTX


Mirati Therapeutics Aktie Analyse

18.07.19 Mirati Therapeutics Hold Deutsche Bank AG
19.06.19 Mirati Therapeutics Neutral B. Riley FBR
05.06.19 Mirati Therapeutics Buy H.C. Wainwright & Co.
03.12.18 Mirati Therapeutics Buy B. Riley FBR
09.07.18 Mirati Therapeutics Outperform Oppenheimer & Co. Inc.
12.03.18 Mirati Therapeutics overweight Barclays Capital
09.01.18 Mirati Therapeutics Buy H.C. Wainwright & Co.
12.10.17 Mirati Therapeutics Buy H.C. Wainwright & Co.
17.11.16 Mirati Therapeutics Buy H.C. Wainwright & Co.
06.06.16 Mirati Therapeutics Outperform Wedbush Morgan Securities Inc.
24.05.16 Mirati Therapeutics Outperform Wedbush Morgan Securities Inc.
09.05.16 Mirati Therapeutics Outperform Wedbush Morgan Securities Inc.
19.10.15 Mirati Therapeutics overweight Barclays Capital
01.06.15 Mirati Therapeutics Hold Brean Capital
08.05.15 Mirati Therapeutics Buy Brean Capital